Cargando…
Facile target validation in an animal model with intracellularly expressed monobodies
Rapidly determining the biological effect of perturbing a site within a potential drug target could guide drug discovery efforts but it remains challenging. Here, we describe a facile target validation approach that exploits monobodies, small synthetic binding proteins that can be fully functionally...
Autores principales: | Gupta, Ankit, Xu, Jing, Lee, Shirley, Tsai, Steven T., Zhou, Bo, Kurosawa, Kohei, Werner, Michael S., Koide, Akiko, Ruthenburg, Alexander J., Dou, Yali, Koide, Shohei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103845/ https://www.ncbi.nlm.nih.gov/pubmed/30013062 http://dx.doi.org/10.1038/s41589-018-0099-z |
Ejemplares similares
-
Monobody Inhibitor Selective to the Phosphatase Domain of SHP2 and its Use as a Probe for Quantifying SHP2 Allosteric Regulation
por: Sha, Fern, et al.
Publicado: (2023) -
Monobodies and other synthetic binding proteins for expanding protein science
por: Sha, Fern, et al.
Publicado: (2017) -
Proof of dual-topology architecture of Fluc F(-) channels with monobody blockers
por: Stockbridge, Randy B., et al.
Publicado: (2014) -
Monobodies as tool biologics for accelerating target validation and druggable site discovery
por: Akkapeddi, Padma, et al.
Publicado: (2021) -
Selective Targeting of SH2 Domain–Phosphotyrosine Interactions of Src Family Tyrosine Kinases with Monobodies
por: Kükenshöner, Tim, et al.
Publicado: (2017)